Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children

NCT02484261 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Contractual/Funding/Accrual

Conditions

Leukemia

Interventions

DRUG: Bortezomib
DRUG: Pravastatin

Sponsor

Reuven Schore

Collaborators

[object Object]
[object Object]